Cleared Traditional

Velacur (K233977) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K233977 · Sonic Incytes · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2024
Decision
261d
Days
Class 2
Risk

K233977 is an FDA 510(k) clearance for the Velacur. Classified as System, Imaging, Pulsed Echo, Ultrasonic (product code IYO), Class II - Special Controls.

Submitted by Sonic Incytes (Vancouver, CA). The FDA issued a Cleared decision on September 4, 2024 after a review of 261 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1560 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Sonic Incytes devices

Submission Details

510(k) Number K233977 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 18, 2023
Decision Date September 04, 2024
Days to Decision 261 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
154d slower than avg
Panel avg: 107d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYO System, Imaging, Pulsed Echo, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Z&B Enterprises, Inc.
Rhona Shanker

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IYO System, Imaging, Pulsed Echo, Ultrasonic

All 215
Devices cleared under the same product code (IYO) and FDA review panel - the closest regulatory comparables to K233977.
EchoGuide (Version 1)
K243479 · Sonavex, Inc. · Apr 2025
Portable Liver Elastography Ultrasound Diagnostic System (Liverscan C)
K242496 · Eieling Technology (Shenzhen) Limited · Nov 2024
SpineUs™ System
K241029 · Verdure Imaging · Oct 2024
SC1 Handheld Ultrasound Imaging system (Model: SC1)
K233579 · Fcu Co., Ltd. · Jun 2024
ACUSON SC2000 Diagnostic Ultrasound System
K233613 · Siemens Medical Solutions USA, Inc. · Jun 2024
B-Ultrasound Diagnostic System
K232895 · Contec Medical Systems Co.,Ltd · May 2024